Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes Read more
Mankind Pharma seeks CDSCO approval for Phase 1 Clinical Trials of patented anti-diabetic molecule Read more
Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes Read more
Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for Lantus SoloSTAR Read more
Eris Lifesciences acquires trademark Zomelis (for Vildagliptin) from Novartis AG for India market Read more